SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015775
Filing Date
2021-11-12
Accepted
2021-11-12 16:02:12
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 1571300
2 EX-31.1 tmb-20210930xex31d1.htm EX-31.1 18453
3 EX-31.2 tmb-20210930xex31d2.htm EX-31.2 18511
4 EX-32.1 tmb-20210930xex32d1.htm EX-32.1 8297
5 EX-32.2 tmb-20210930xex32d2.htm EX-32.2 8785
  Complete submission text file 0001558370-21-015775.txt   6080061

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210930.xsd EX-101.SCH 41563
7 EX-101.CAL tmb-20210930_cal.xml EX-101.CAL 49285
8 EX-101.DEF tmb-20210930_def.xml EX-101.DEF 157082
9 EX-101.LAB tmb-20210930_lab.xml EX-101.LAB 347768
10 EX-101.PRE tmb-20210930_pre.xml EX-101.PRE 275651
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 1017879
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 211403263
SIC: 2834 Pharmaceutical Preparations